Satya Saxena

Satya Saxena

Company: Eisai

Job title: Director, Global Proteomics, Clinical Pharmacology and Translational Medicine


Enabling Clinical Uptake of Higher-Plex Technologies in IHC/ISH 3:00 pm

• Multiplex immunohistochemistry and in situ hybridization assays are used in early therapeutic development and are becoming increasingly pervasive within the diagnostic workflow • More complicated clinical questions are arising that may require multi-omics-based clinical diagnostic assays • Issues in translating diagnostic data from preclinical to translational to clinical use • Transition points of the…Read more

day: Day 2 Track A PM

Utilizing Multimodal Network-Driven Biomarker Discovery for Alzheimer’s Disease Diagnosis & Monitoring 12:20 pm

Building modules of co-expressing proteins linked to various biological functions, organelles and specific cell types to facilitate network-driven biomarker discovery Identifying novel proteomic alterations to help in deeper understanding of disease heterogeneity and pathophysiology of neurodegeneration Developing biomarker signature(s) to facilitate clinical management of Alzheimer’s disease through precise disease staging and prediction of disease progression,…Read more

day: Day 2 Track A AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.